329 related articles for article (PubMed ID: 24063904)
1. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
2. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
[TBL] [Abstract][Full Text] [Related]
3. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.
Bouvier AM; Remontet L; Hédelin G; Launoy G; Jooste V; Grosclaude P; Belot A; Lacour B; Estève J; Bossard N; Faivre J;
Cancer; 2009 Oct; 115(19):4616-24. PubMed ID: 19569252
[TBL] [Abstract][Full Text] [Related]
4. Changes in the risk of death from cancer up to five years after diagnosis in elderly patients: a study of five common cancers.
Colonna M; Bossard N; Remontet L; Grosclaude P;
Int J Cancer; 2010 Aug; 127(4):924-31. PubMed ID: 19998335
[TBL] [Abstract][Full Text] [Related]
5. Long-term net survival in patients with colorectal cancer in France: an informative contribution of recent methodology.
Rollot F; Chauvenet M; Roche L; Hamza S; Lepage C; Faivre J; Bouvier AM
Dis Colon Rectum; 2013 Oct; 56(10):1118-24. PubMed ID: 24022528
[TBL] [Abstract][Full Text] [Related]
6. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
[TBL] [Abstract][Full Text] [Related]
7. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
8. Leading cancers--changes in five-year relative survival.
Ellison LF; Gibbons L
Health Rep; 2004 Mar; 15(2):19-32. PubMed ID: 15151028
[TBL] [Abstract][Full Text] [Related]
9. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
[TBL] [Abstract][Full Text] [Related]
10. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.
Howlader N; Mariotto AB; Woloshin S; Schwartz LM
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):255-64. PubMed ID: 25417239
[TBL] [Abstract][Full Text] [Related]
11. Variation, precision and validity of 1-year survival estimates for lung, breast, colon and prostate cancer in South East England primary care trusts.
Lake J; Mak V; Møller H; Davies EA
Public Health; 2012 Jan; 126(1):57-63. PubMed ID: 22153886
[TBL] [Abstract][Full Text] [Related]
12. [Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005].
Colonna M; Bossard N; Mitton N; Remontet L; Belot A; Delafosse P; Grosclaude P;
Rev Epidemiol Sante Publique; 2008 Dec; 56(6):434-40. PubMed ID: 19010627
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
Holmes S; Griffith EJ; Musto G; Minuk GY
Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
[TBL] [Abstract][Full Text] [Related]
14. The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients.
Feuer EJ; Lee M; Mariotto AB; Cronin KA; Scoppa S; Penson DF; Hachey M; Cynkin L; Carter GA; Campbell D; Percy-Laurry A; Zou Z; Schrag D; Hankey BF
Cancer; 2012 Nov; 118(22):5652-62. PubMed ID: 22569947
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of the four major cancers in South Dakota.
Clarke J
S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
[TBL] [Abstract][Full Text] [Related]
16. Five-year relative survival from prostate, breast, colorectal and lung cancer.
Ellison LF; Gibbons L;
Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
[TBL] [Abstract][Full Text] [Related]
17. How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden.
Eloranta S; Adolfsson J; Lambert PC; Stattin P; Akre O; Andersson TM; Dickman PW
Cancer Causes Control; 2013 Mar; 24(3):505-15. PubMed ID: 23296456
[TBL] [Abstract][Full Text] [Related]
18. Conditional net survival: Relevant prognostic information for colorectal cancer survivors. A French population-based study.
Drouillard A; Bouvier AM; Rollot F; Faivre J; Jooste V; Lepage C
Dig Liver Dis; 2015 Jul; 47(7):597-601. PubMed ID: 25911573
[TBL] [Abstract][Full Text] [Related]
19. Quantifying differences in breast cancer survival between England and Norway.
Lambert PC; Holmberg L; Sandin F; Bray F; Linklater KM; Purushotham A; Robinson D; Møller H
Cancer Epidemiol; 2011 Dec; 35(6):526-33. PubMed ID: 21606014
[TBL] [Abstract][Full Text] [Related]
20. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
